[Results of a clinical study on the vasodilator 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191)].
D001158:Arteries; D001161:Arteriosclerosis / Q000188:drug therapy; D001775:Blood Circulation / Q000187:drug effects; D002560:Cerebrovascular Circulation / Q000187:drug effects; D004361:Drug Tolerance; D006801:Humans; D014652:Vascular Diseases / Q000097:blood / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D014970:Xanthines / Q000008:administration & dosage / Q000627:therapeutic use*
D014665:Vasodilator Agents; D014970:Xanthines
Ergebnisse der klinischen Prüfung des Vasotherapeuticums 3,7-Dimethyl-1-(5-oxo-hexyl)-xanthin (BL 191.